Vyome Holdings Relocates HQ to Cambridge, MA
Ticker: HIND · Form: 8-K · Filed: Oct 3, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Vyome Holdings, Inc (HIND) |
| Form Type | 8-K |
| Filed Date | Oct 3, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, filing-update, administrative
TL;DR
Vyome Holdings moving HQ to Cambridge, MA. Formerly ReShape Lifesciences.
AI Summary
Vyome Holdings, Inc. filed an 8-K on October 3, 2025, reporting an event on September 29, 2025. The filing indicates a change in the company's principal executive offices from San Clemente, CA to Cambridge, MA. The company was formerly known as ReShape Lifesciences Inc. and Obalon Therapeutics Inc.
Why It Matters
A change in principal executive offices can signal strategic shifts, potential integration with local biotech ecosystems, or operational restructuring.
Risk Assessment
Risk Level: low — This filing primarily concerns administrative changes and does not appear to involve significant financial or operational risks.
Key Players & Entities
- Vyome Holdings, Inc. (company) — Registrant
- ReShape Lifesciences Inc. (company) — Former company name
- Obalon Therapeutics Inc (company) — Former company name
- September 29, 2025 (date) — Date of earliest event reported
- October 3, 2025 (date) — Filing date
- Cambridge, MA (location) — New principal executive offices
- San Clemente, CA (location) — Previous principal executive offices
FAQ
What is the new address for Vyome Holdings, Inc.'s principal executive offices?
The new address for Vyome Holdings, Inc.'s principal executive offices is Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 29, 2025.
What were Vyome Holdings, Inc.'s previous names?
Vyome Holdings, Inc. was formerly known as ReShape Lifesciences Inc. and Obalon Therapeutics Inc.
In which state is Vyome Holdings, Inc. incorporated?
Vyome Holdings, Inc. is incorporated in Delaware.
What is the SIC code for Vyome Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Vyome Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 436 words · 2 min read · ~1 pages · Grade level 10.9 · Accepted 2025-10-03 16:44:07
Key Financial Figures
- $0.001 — ich registered Common stock, par value $0.001 per share HIND The Nasdaq Capital M
Filing Documents
- ea0260282-8k_vyome.htm (8-K) — 24KB
- ea026028201ex99-1_vyome.htm (EX-99.1) — 11KB
- 0001213900-25-096156.txt ( ) — 205KB
- hind-20250929.xsd (EX-101.SCH) — 3KB
- hind-20250929_lab.xml (EX-101.LAB) — 33KB
- hind-20250929_pre.xml (EX-101.PRE) — 22KB
- ea0260282-8k_vyome_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On September 29, 2025, Vyome Holdings, Inc. (the "Company") issued a press release that it acquired Oculo, Inc., an AI startup launched at the Massachusetts Institute of Technology. A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued September 29, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VYOME HOLDINGS, INC. October 3, 2025 By: /s/ Venkat Nelabhotla Name: Venkat Nelabhotla Title: President & Chief Executive Officer 2